We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Dec 2017 07:00

RNS Number : 5152A
Interserve PLC
29 December 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Interserve Plc

LEI: 549300MVYY4EZCRFHZ09

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

The Goldman Sachs Group, Inc.

City and country of registered office (if applicable)

Corporation Trust Center, 1209 Orange Street,

Wilmington DE 19801, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

Goldman Sachs International

City and country of registered office (if applicable)

Peterborough Court, 133 Fleet Street, London

EC4A 2BB, UK

5. Date on which the threshold was crossed or reachedvi:

22/12/2017

6. Date on which issuer notified:

28/12/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

0.018%

10.292%

10.311%

145,714,120

Position of previous notification (if

applicable)

0.100%

10.047%

10.147%

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0001528156

26,663

0.018%

SUBTOTAL 8. A

26,663

0.018%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

Open

13,605,691

9.337%

SUBTOTAL 8. B 1

13,605,691

9.337%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration

Exercise/

Physical or cash

Number of voting rights

% of voting rights

datex

Conversion Period xi

settlementxii

CFD

18-Aug-2027

Cash

613,423

0.421%

CFD

21-Jul-2027

Cash

244,364

0.168%

CFD

13-Oct-2027

Cash

243,228

0.167%

CFD

03-Nov-2027

Cash

63,596

0.044%

CFD

16-Dec-2027

Cash

56,958

0.039%

CFD

23-Dec-2027

Cash

52,719

0.036%

CFD

29-Sep-2027

Cash

42,434

0.029%

CFD

23-Dec-2027

Cash

33,443

0.023%

CFD

17-Dec-2027

Cash

13,304

0.009%

CFD

16-Dec-2027

Cash

9,111

0.006%

CFD

23-Dec-2027

Cash

6,629

0.005%

CFD

01-Dec-2027

Cash

6,552

0.004%

CFD

23-Dec-2027

Cash

5,751

0.004%

SUBTOTAL 8.B.2

1,391,512

0.955%

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Goldman Sachs Group, Inc.

Goldman Sachs (UK) L.L.C.

Goldman Sachs Group UK Limited

Goldman Sachs

International

10.133%

10.133%

The Goldman Sachs Group, Inc.

Goldman Sachs & Co. LLC

The Goldman Sachs Group, Inc.

GSAM Holdings LLC

Goldman Sachs Asset Management, L.P.

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

 

11. Additional informationxvi

Please note, percentages, shares and instruments have been rounded to 3 decimal places which could result to a possibility of a rounding error.

 

General email contact:

shareholderdisclosures@gs.com

 

 

Place of completion

London

Date of completion

28/12/2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFVLLLDLFZFBK
Date   Source Headline
18th Oct 20179:25 amRNSHolding(s) in Company
16th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 20177:30 amRNSStatement following recent media coverage
12th Oct 20173:46 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSInterserve wins Leeds housing development contract
6th Oct 20179:08 amRNSHolding(s) in Company
5th Oct 20178:50 amRNSHolding(s) in Company
3rd Oct 20172:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20177:00 amRNSInterserve-led consortium chosen for £85m project
2nd Oct 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Sep 201711:33 amRNSHolding(s) in Company
27th Sep 20177:00 amRNSInterserve wins place on £8bn CMA framework
26th Sep 201710:49 amRNSHolding(s) in Company
26th Sep 201710:42 amRNSHolding(s) in Company
20th Sep 20179:03 amRNSHolding(s) in Company
19th Sep 20174:26 pmRNSHolding(s) in Company
19th Sep 20179:45 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSHolding(s) in Company
18th Sep 20172:09 pmRNSDirector/PDMR Shareholding
18th Sep 20171:48 pmRNSHolding(s) in Company
18th Sep 201712:00 pmRNSDirector/PDMR Shareholding
18th Sep 201710:08 amRNSHolding(s) in Company
18th Sep 201710:04 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSMark Whiteling appointed Chief Financial Officer
15th Sep 20173:33 pmRNSHolding(s) in Company
15th Sep 20172:16 pmRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSTrading Update
13th Sep 20179:18 amRNSDirector/PDMR Shareholding
12th Sep 201711:44 amRNSDirector/PDMR Shareholding
12th Sep 201710:16 amRNSHolding(s) in Company
11th Sep 201711:13 amRNSHolding(s) in Company
6th Sep 20179:24 amRNSHolding(s) in Company
6th Sep 20177:00 amRNSInterserve wins £90m DfT FM contract
1st Sep 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Aug 201711:42 amRNSHolding(s) in Company
24th Aug 20174:27 pmRNSHolding(s) in Company
24th Aug 201710:42 amRNSHolding(s) in Company
24th Aug 20179:18 amRNSPublication of Half-Year Report
24th Aug 20178:46 amRNSHolding(s) in Company
17th Aug 20179:33 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSInterserve and Amec Foster Wheeler Joint Venture
14th Aug 20172:17 pmRNSHolding(s) in Company
14th Aug 20172:16 pmRNSHolding(s) in Company
9th Aug 20173:01 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSHalf-Year Results 2017
13th Jul 20174:25 pmRNSDirector/PDMR Shareholding
12th Jul 201712:52 pmRNSDirector/PDMR Shareholding
12th Jul 20179:44 amRNSHolding(s) in Company
3rd Jul 20177:00 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.